Quick Answer
Glucotrack, Inc. reported Research And Development Expense of $9.81 million for the year ending 2025.
- Glucotrack, Inc. showed an increase of +3.3% in Research And Development Expense from 2024 to 2025.
- This data is from Glucotrack, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Glucotrack, Inc.'s Research And Development Expense has grown by 876.3%.
- Historical annual values: Fiscal year 2025: $9.81 million | Fiscal year 2024: $9.50 million | Fiscal year 2023: $4.70 million | Fiscal year 2022: $1.97 million | Fiscal year 2021: $1.81 million | Fiscal year 2020: $1.53 million | Fiscal year 2019: $1.61 million | Fiscal year 2018: $3.03 million | Fiscal year 2017: $3.21 million | Fiscal year 2016: $2.88 million | Fiscal year 2015: $2.27 million | Fiscal year 2014: $1.85 million | Fiscal year 2013: $1.99 million | Fiscal year 2012: $1.92 million | Fiscal year 2011: $1.79 million | Fiscal year 2010: $934.1 thousand | Fiscal year 2009: $1.01 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: